Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma

British Journal of Cancer

Volumn 73, Issue 12, 1996, Pages 1498-1502

  Tsai, J F ^a   Jeng, J E ^a   Ho, M S ^b   Chang, W Y ^a   Hsieh, M Y ^a   Lin, Z Y ^a   Tsai, J H ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Antibodies to hepatitis C virus; Hepatitis B e antigen; Hepatitis B surface antigen; Hepatocellular carcinoma

Indexed keywords

ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK FACTOR;

EID: 0030038772     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.283     Document Type: Article

References (33)

1. CHEN CJ, LIANG KY, CHANG AH, CHANG YC, LU SN, LIAW YF, CHANG WY, SHEEN MC AND LIN TM. (1991). Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology, 13, 398-406.
2. CHEN CJ, TSENG SF, LU SF, LIN HC, YOU SL, CHEN CS, HWANG SJ, HSIEH SF AND HSU ST. (1992). Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan. J. Med. Virol., 8, 97-101.
3. CHEN DS. (1993). Natural history of chronic hepatitis B virus infection: New light on old story. J. Gastroenterol. Hepatol., 8, 470-475.
4. CHEN DS, LAI MY AND SUNG JL. (1984). δ-agent infection in chronic liver diseases and hepatocellular carcinoma-an infrequent finding in Taiwan. Hepatology, 4, 502-503.
5. GALLOWAY DA AND MCDOUGALL JK. (1983). The oncogenic potential of herpes simplex viruses: Evidence of a 'hit and run' mechanism. Nature, 302, 21-24.
6. GUPTA S AND SHAFRITZ DA. (1994). Viral mechanisms in hepatic oncogenesis. In The Liver: Biology and Pathobiology. Third ed., Arias IM, Boyer JL, Fausto N, Jacoby WB, Schachter DA, Shafritz DA. (eds), pp. 1429-1453. Raven Press: New York.
7. JENG JE AND TSAI JF. (1991). Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan. J. Med. Virol., 34, 74-77.
8. KEW MC AND POPPER H. (1984). Relationship between hepatocellular carcinoma and cirrhosis. Semin. Liver Dis., 4, 136-145.
9. LEUNG NW, TAM JS, LAU GT, LEUNG TW, LAU WY AND LI AK. (1994). Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus-related chronic liver diseases. Cancer, 73, 1143-1148.
10. LIN TM, CHEN CJ, LU SN, CHANG AS, CHANG YC, HSU ST, LIU JY, LIAW YF AND CHANG WY. (1991). Hepatitis B virus e antigen and primary hepatocellular carcinoma. Anticancer Res., 11, 2063-2065.
11. POPPER H, THUNG SN, MCMAHON BJ, LANIER A.P., HAWKINS I AND ALBERTS SR. (1988). Evolution of hepatocellular carcinoma associated with chronic hepatitis B virus infection in Alaska Eskimos. Arch. Pathol. Lab. Med., 112, 498-504.
12. RAIMONDO G, CAMPO S, SMEDILE V, RODINO G, SARDO MA, BRANCATELLI S, VILLARI D, PERNICE M, LONGO G AND SQUADRITO G. (1991). Hepatitis B virus variant, with a deletion in the pre-S2 and two translational stop codons in the precore region, in a patient with hepatocellular carcinoma. J. Hepatol., 13 (suppl. 4), S74-S77.
13. SCHIRMACHER P, ROGLER CE AND DIENES HP (1993). Current pathogenetic and molecular concepts in viral liver carcinogenesis. Virchows Arch. B Cell Pathol., 63, 71-89.
14. THOMAS HC AND CARMAN WF. (1994). Envelop and precore core variants of hepatitis B virus. Gastroenterol. Clin. N. Am., 23, 499-514.
15. TSAI JF, MARGOLIS HS, FIELDS HA, CHANG WY AND TSAI JH. (1990a). Hepatitis delta virus superinfection among patients with chronic hepatitis B in southern Taiwan. Scand. J. Infect. Dis., 22, 403-405.
16. TSAI JF, MARGOLIS HS, FIELDS HA, NAINAN OV, CHANG WY AND TSAI JH. (1990b). Immunoglobulin and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis with hepatitis delta virus infection. J. Med. Virol., 30, 25-26.
17. TSAI JF, TSAI JH AND CHANG WY. (1990c). Relationship of serum α-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Gastroenterol. Jpn., 25, 388-393.
18. TSAI JF, TSAI JH, CHANG WY AND TON TC. (1991). Elevation of circulating immune complexes and its relationship to α-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Cancer Invest., 9, 137-143.
19. TSAI JF, CHANG WY, JENG JE, WANG LY, HSIEH MY, CHEN SC, CHUANG WL, LIN ZY AND TSAI JH. (1993). Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J. Med. Virol., 41, 296-300.
20. TSAI JF, CHANG WY, JENG JE, HO MS, LIN ZY AND TSAI JH. (1994a). Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver, 14, 98-102.
21. TSAI JF, CHANG WY, JENG JE, HO MS, LIN ZY AND TSAI JH. (1994b). Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Br. J. Cancer, 69, 1157-1159.
22. TSAI JF, JENG JE, HO MS, CHANG WY, LIN ZY AND TSAI JH. (1994c). Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int. J. Cancer, 56, 619-621.
23. TSAI JF, JENG JE, CHANG WY, LIN ZY AND TSAI JH. (1994b). Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand. J. Gastroenterol., 29, 550-552.
24. TSAI JF, CHANG WY, JENG JE, HO MS, EIN ZY AND TSAI JH. (1994c). Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J. Med. Virol. 44, 92-95.
25. TSAI JF, MARGOLIS HS, JENG JE, HO MS, KO YC, CHANG WY, LIN ZY AND TSAI JH. (1994f). Association between hepatitis B and C virus infection and Chinese hepatocellular carcinoma: A case control study. In Viral Hepatitis and Liver Disease, Nishioka K, Suzuki H, Mishiro S, Oda T. (eds) pp. 697 700. Springer-Verlag: Tokyo.
26. TSAI JF, JENG JE, CHANG WY, LIN ZY AND TSAI JH. (1994g). Antibodies to hepatitis E virus among Chinese patients with acute hepatitis in Taiwan. J. Med. Virol., 43, 341-344.
27. TSAI JE, JENG JE, CHANG, WY, LIN ZY AND TSAI JH. (1994h). Antibodies to hepatitis E and A viruses among patients with non-alcoholic chronic liver disease in Taiwan. Scand. J. Gastroenterol., 29, 674-676.
28. TSAI JF, JENG JE, CHANG WY, HO MS, LIN ZY AND TSAI JH. (1995a), Circulating immune complexes in chronic hepatitis C. J. Med. Virol., 46, 12-17.
29. TSAI JF, JENG JE, CHANG WY, HO MS, LIN ZY AND TSAI JH. (1995b). Increased IgM-containing circulating immune complexes in patients co-infected with hepatitis C and hepatitis B. Medicine, 74, 136-143.
30. TSAI JF, JENG JE, CHANG WY, HO MS, LIN ZY AND TSAI JH. (1995c). Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection. Clin. Immunol. Immunopathol., 75, 39-44.
31. TSAI JF, JENG JE, HO MS, CHANG WY, LIN ZY AND TSAI JH. (1995b). Clinical evaluation of serum α-fetoprotein and circulating immune complexes as tumor markers of hepatocellular carcinoma. Br. J. Cancer, 72, 442-446.
32. TSAI JF, JENG JE, HO MS, CHANG WY, LIN ZY AND TSAI JH. (1996). Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J. Hepatol. (in press).
33. ZAMAN S, KHAN M, ALAM K AND WILLIAMS R. (1995). Primary hepatocellular carcinoma and viral hepatitis B and C infection in Bangladeshi subjects. J. Trop. Med. Hyg., 98, 64-68.